6 order that directed the agency to release 55,000 pages monthly starting on March 1. The judge is also expected to take up the FDA's logistical concerns about his Jan. Pittman scheduled a hearing for Friday to consider Pfizer's bid to intervene. The FDA said on Tuesday in its court filing that it welcomed the opportunity to coordinate with Pfizer amid what the agency called the "unusual and indeed extraordinary circumstances" of the case. government agencies control the release of information under federal public-records laws, but companies can challenge and even sue to block the disclosure of certain details. On Tuesday night, the group of doctors and scientists who sued last year over public access to the FDA's Pfizer licensing records said in a court filing that the company's bid to jump into the lawsuit was untimely because the plaintiffs have not challenged any redactions to requested records.Įarlier this month, the judge ordered a fast-track release of hundreds of thousands of documents, calling the case "of paramount public importance." 21 it wanted a role in the proceedings to help the FDA avoid "inappropriately" disclosing trade secret and confidential commercial information. Food and Drug Administration used in licensing the company's COVID-19 vaccine, a litigation move that plaintiffs who are suing for the data say is premature. (Reuters) - Pfizer Inc wants to intervene in a Texas federal lawsuit seeking information from the U.S. Plaintiffs contend Pfizer's bid in Texas federal court is untimely.Drug company wants to protect any trade secrets, business proprietary information.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |